Like Biocon, prefer Rallis India: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I like Biocon, it has come in my buy list repeatedly and the chances are it is going much higher. Dr Lal PathLabs has a very reduced amount of patterns, bars on the chart. The days are not enough to give a chartist view.""Apart from the Nifty there are number of midcaps stocks were buying is possible. One of them is Rallis India and the other is JK Lakshmi Cement. Earlier there was a talk of cement companies. So, JK Lakshmi Cement is coming out again of a consolidation. Both these midcaps are good ideas."